Cell Biotech Co. Ltd Capital Reinvestment Ratio
Cell Biotech Co. Ltd capital reinvestment ratio. Cell Biotech Co. Ltd (049960) has a Capital Reinvestment Ratio of 0.55x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩4.15 Billion) in capital expenditures (₩2.29 Billion). See Cell Biotech Co. Ltd (049960) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cell Biotech Co. Ltd (2011–2024)
Capital reinvestment ratio of Cell Biotech Co. Ltd from 2011 to 2024. This chart tracks Cell Biotech Co. Ltd's Capital Reinvestment Ratio across 14 annual periods. See Cell Biotech Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cell Biotech Co. Ltd Capital Reinvestment Ratio by Year (2011–2024)
Cell Biotech Co. Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 049960 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩19.27 Billion | ₩1.28 Billion | ▼ -69.2% |
| 2023 | 0.22x | ₩7.82 Billion | ₩1.69 Billion | ▲ +3.4% |
| 2022 | 0.21x | ₩12.81 Billion | ₩2.67 Billion | ▲ +266.0% |
| 2021 | 0.06x | ₩14.89 Billion | ₩848.59 Million | ▼ -82.3% |
| 2020 | 0.32x | ₩9.56 Billion | ₩3.08 Billion | ▼ -65.2% |
| 2019 | 0.93x | ₩10.23 Billion | ₩9.47 Billion | ▲ +81.9% |
| 2018 | 0.51x | ₩13.98 Billion | ₩7.11 Billion | ▲ +114.0% |
| 2017 | 0.24x | ₩22.53 Billion | ₩5.36 Billion | ▲ +98.3% |
| 2016 | 0.12x | ₩17.99 Billion | ₩2.16 Billion | ▼ -35.4% |
| 2015 | 0.19x | ₩18.24 Billion | ₩3.38 Billion | ▲ +32.8% |
| 2014 | 0.14x | ₩9.91 Billion | ₩1.38 Billion | ▼ -80.1% |
| 2013 | 0.70x | ₩8.99 Billion | ₩6.31 Billion | ▲ +29.0% |
| 2012 | 0.54x | ₩6.17 Billion | ₩3.36 Billion | ▲ +411.4% |
| 2011 | 0.11x | ₩5.45 Billion | ₩580.85 Million | — |